December 9, 2015 9:56 AM | 1 min read
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Analysts at Jefferies upgraded
Computer Sciences Corporation (NYSE: CSC) from Hold to Buy. Computer Sciences shares closed at $30.46 on Tuesday.Analysts at Nomura upgraded
Intel Corporation (NASDAQ: INTC) from Neutral to Buy. The price target for Intel has been raised from $33 to $42. Intel shares closed at $34.75 on Tuesday.Baird upgraded
Agilent Technologies Inc (NYSE: A) from Neutral to Outperform. The price target for Agilent has been raised to $48. Agilent shares closed at $41.17 on Tuesday.Deutsche Bank upgraded
QEP Resources Inc (NYSE: QEP) from Hold to Buy. QEP Resources shares closed at $12.88 on Tuesday.Analysts at Nomura upgraded
Maxim Integrated Products Inc. (NASDAQ: MXIM) from Neutral to Buy. Maxim Integrated Products shares closed at $36.60 on Tuesday.Analysts at Cowen & Company upgraded
Accretive Health, Inc. (OTCMKTS: ACHI) from Market Perform to Outperform. Accretive Health shares closed at $2.79 on Tuesday. Analysts at Jefferies upgraded
Ball Corporation (NYSE: BLL) from Hold to Buy. Ball shares closed at $67.46 on Tuesday.Bank of America upgraded
Total SA (ADR) (NYSE: TOT) from Hold to Buy. Total shares closed at $46.10 on Tuesday.Canaccord Genuity upgraded
Toronto-Dominion Bank (NYSE: TD) from Hold to Buy. Toronto-Dominion Bank shares closed at $39.12 on Tuesday.KLR Group upgraded
Matador Resources Co (NYSE: MTDR) from Reduce to Hold. Matador Resources shares closed at $21.16 on Tuesday.
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.